Personal information

No personal information available

Activities

Employment (1)

Rigshospitalet Center for Kræft og Organsygdomme: Kobenhavn, DK

2022-11-01 to 2034-11-01 | Afdelingslæge (Intensive Care)
Employment
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen

Education and qualifications (2)

Københavns Universitet Sundhedsvidenskabelige Fakultet: Kobenhavn, DK

2014-02-01 to 2018-02-20 | PhD
Education
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen

Københavns Universitet Sundhedsvidenskabelige Fakultet: Kobenhavn, DK

2010-06-25 | Medical Doctor
Education
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen

Works (17)

Goal‐directed fluid removal with furosemide versus placebo in intensive care patients with fluid overload: A randomised, blinded trial (GODIF trial—First version)

Acta Anaesthesiologica Scandinavica
2023-04 | Journal article
Contributors: Sine Wichmann; Martin Schønemann‐Lund; Anders Perner; Theis S. Itenov; Theis Lange; Christian Gluud; Rasmus E. Berthelsen; Anne C. Brøchner; Jørgen Wiis; Morten H. Bestle
Source: check_circle
Crossref

Goal directed fluid removal with furosemide versus placebo in intensive care patients with fluid overload: a trial protocol for a randomised, blinded trial (GODIF Trial).

Acta anaesthesiologica Scandinavica
2022-07 | Journal article
Contributors: Wichmann S; Itenov TS; Berthelsen RE; Lange T; Perner A; Gluud C; Lawson-Smith P; Nebrich L; Wiis J; Brøchner AC et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central
grade
Preferred source (of 2)‎

Loop diuretics in adult intensive care patients with fluid overload: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Annals of intensive care
2022-06 | Journal article
Contributors: Wichmann S; Barbateskovic M; Liang N; Itenov TS; Berthelsen RE; Lindschou J; Perner A; Gluud C; Bestle MH
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Co-administration of iloprost and eptifibatide in septic shock (CO-ILEPSS)-a randomised, controlled, double-blind investigator-initiated trial investigating safety and efficacy.

Critical care (London, England)
2019-09 | Journal article
Contributors: Berthelsen RE; Ostrowski SR; Bestle MH; Johansson PI
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central
grade
Preferred source (of 2)‎

Forced fluid removal in intensive care patients with acute kidney injury: The randomised FFAKI feasibility trial.

Acta anaesthesiologica Scandinavica
2018-04 | Journal article
Contributors: Berthelsen RE; Perner A; Jensen AK; Rasmussen BS; Jensen JU; Wiis J; Behzadi MT; Bestle MH
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central
grade
Preferred source (of 2)‎

Fluid accumulation during acute kidney injury in the intensive care unit.

Acta anaesthesiologica Scandinavica
2018-03 | Journal article
Contributors: Berthelsen RE; Perner A; Jensen AK; Jensen JU; Bestle MH
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central
grade
Preferred source (of 2)‎

Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine
2018-03 | Journal article
Contributors: Itenov TS; Berthelsen RE; Jensen JU; Gerds TA; Pedersen LM; Strange D; Thormar K; Løken J; Andersen MH; Tousi H et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Forced fluid removal versus usual care in intensive care patients with high-risk acute kidney injury and severe fluid overload (FFAKI): study protocol for a randomised controlled pilot trial.

Trials
2017-04 | Journal article
Contributors: Berthelsen RE; Itenov T; Perner A; Jensen JU; Ibsen M; Jensen AEK; Bestle M
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

ESICM LIVES 2016: part one : Milan, Italy. 1-5 October 2016.

2016-09 | Journal article
Contributors: Bos L; Schouten L; van Vught L; Wiewel M; Ong D; Cremer O; Artigas A; Martin-Loeches I; Hoogendijk A; van der Poll T et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

ESICM LIVES 2016: part three : Milan, Italy. 1-5 October 2016.

2016-09 | Journal article
Contributors: Velasquez T; Mackey G; Lusk J; Kyle UG; Fontenot T; Marshall P; Shekerdemian LS; Coss-Bu JA; Nishigaki A; Yatabe T et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

ESICM LIVES 2016: part three : Milan, Italy. 1–5 October 2016

Intensive care medicine experimental
2016-09 | Journal article
Contributors: Velasquez T; Mackey G; Lusk J; Kyle U; Fontenot T; Marshall P; Shekerdemian L; Coss-Bu J; Nishigaki A; Yatabe T et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial.

2016-09 | Journal article
Contributors: Hjortrup PB; Haase N; Bundgaard H; Thomsen SL; Winding R; Pettilä V; Aaen A; Lodahl D; Berthelsen RE; Christensen H et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Pre-emptive treatment with fibrinogen concentrate for postpartum haemorrhage: randomized controlled trial.

2015-04 | Journal article
Contributors: Wikkelsø AJ; Edwards HM; Afshari A; Stensballe J; Langhoff-Roos J; Albrechtsen C; Ekelund K; Hanke G; Secher EL; Sharif HF et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Effect of intermediate care on mortality following emergency abdominal surgery. The InCare trial: study protocol, rationale and feasibility of a randomised multicentre trial.

2013 | Journal article
Contributors: Vester-Andersen M; Waldau T; Wetterslev J; Møller MH; Rosenberg J; Jørgensen LN; Gillesberg I; Jakobsen HL; Hansen EG; Poulsen LM et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trial.

2013 | Journal article
Contributors: Wittbrodt P; Haase N; Butowska D; Winding R; Poulsen JB; Perner A; 6S trial group; Scandinavian Critical Care Trials Group
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Spontaneous sublingual haematoma in a patient treated with warfarin.

2013-04 | Journal article
Contributors: Berthelsen RE; Tadbiri S; Rosenstock CV
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central

Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis.

2012-07 | Journal article
Contributors: Perner A; Haase N; Guttormsen AB; Tenhunen J; Klemenzson G; Åneman A; Madsen KR; Møller MH; Elkjær JM; Poulsen LM et al.
Source: Self-asserted source
Rasmus Ehrenfried Berthelsen via Europe PubMed Central